Recombinant multi-species DHX36 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DHX36 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the DEAH-box family of RNA-dependent NTPases which are named after the conserved amino acid sequence Asp-Glu-Ala-His in motif II. The protein encoded by this gene has been shown to enhance the deadenylation and decay of mRNAs with 3'-UTR AU-rich elements (ARE-mRNA). The protein has also been shown to resolve into single strands the highly stable tetramolecular DNA configuration (G4) that can form spontaneously in guanine-rich regions of DNA. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2810407E23Rik,ATP-dependent DNA/RNA helicase DHX36,DDX36,DEAD/H box polypeptide 36,DEAH-box protein 36,DHX36,Ddx36,Dhx36,G4-resolvase-1 (G4R1),G4R1,MLE-like protein 1,MLEL1,RHAU,RNA helicase associated with AU-rich element protein,mKIAA1488

Target products collectionGo to DHX36 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0693-Ag-1/ GM-Tg-hg-IP0693-Ag-2 Human DHX36 protein Human
GM-Tg-rg-IP0693-Ag-1/ GM-Tg-rg-IP0693-Ag-2 Rat DHX36 protein Rat
GM-Tg-mg-IP0693-Ag-1/ GM-Tg-mg-IP0693-Ag-2 Mouse DHX36 protein Mouse
GM-Tg-cynog-IP0693-Ag-1/ GM-Tg-cynog-IP0693-Ag-2 Cynomolgus/Rhesus macaque DHX36 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0693-Ag-1/ GM-Tg-felg-IP0693-Ag-2 Feline DHX36 protein Feline
GM-Tg-cang-IP0693-Ag-1/ GM-Tg-cang-IP0693-Ag-2 Canine DHX36 protein Canine
GM-Tg-bovg-IP0693-Ag-1/ GM-Tg-bovg-IP0693-Ag-2 Bovine DHX36 protein Bovine
GM-Tg-equg-IP0693-Ag-1/ GM-Tg-equg-IP0693-Ag-2 Equine DHX36 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0693-Ag-1/ GM-Tg-hg-IP0693-Ag-2; GM-Tg-rg-IP0693-Ag-1/ GM-Tg-rg-IP0693-Ag-2;
GM-Tg-mg-IP0693-Ag-1/ GM-Tg-mg-IP0693-Ag-2; GM-Tg-cynog-IP0693-Ag-1/ GM-Tg-cynog-IP0693-Ag-2;
GM-Tg-felg-IP0693-Ag-1/ GM-Tg-felg-IP0693-Ag-2; GM-Tg-cang-IP0693-Ag-1/ GM-Tg-cang-IP0693-Ag-2;
GM-Tg-bovg-IP0693-Ag-1/ GM-Tg-bovg-IP0693-Ag-2; GM-Tg-equg-IP0693-Ag-1/ GM-Tg-equg-IP0693-Ag-2
Products Name DHX36 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DHX36
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DHX36 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.